Immuneering Corporation Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings
Immuneering Corporation (IMRX) reported Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings · last filed 2023-05-04
- Immuneering Corporation other-than-temporary impairment loss, debt securities, portion recognized in earnings for the quarter ending 2023-03-31 was $0.00.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings 3 month |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |